Skip to main content
SpringerLink
Log in

Incretin mimetics potential link with pancreatic pre-cancer

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • FDA. FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes. Internet Document : 15 Mar 2013. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Incretin mimetics potential link with pancreatic pre-cancer. Reactions Weekly 1444, 5 (2013). https://doi.org/10.1007/s40278-013-2020-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-2020-6

Search

Navigation